GlobalData's clinical trial report, "Fistula Global Clinical Trials Review, H1, 2012" provides data on the Fistula clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fistula. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Fistula. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords
Fistula Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Fistula , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Fistula
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Fistula
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Fistula Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Anterogen Co., Ltd.
Clinical Trial Overview of Anterogen Co., Ltd.
Cellerix, S.A.
Clinical Trial Overview of Cellerix, S.A.
Ipsen Inc.
Clinical Trial Overview of Ipsen Inc.
Ocera Therapeutics, Inc.
Clinical Trial Overview of Ocera Therapeutics, Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Vanderbilt University
Clinical Trial Overview of Vanderbilt University
Hospital Universitario La Paz
Clinical Trial Overview of Hospital Universitario La Paz
Leiden University Medical Center
Clinical Trial Overview of Leiden University Medical Center
Hospital Universitario Virgen de la Arrixaca
Clinical Trial Overview of Hospital Universitario Virgen de la Arrixaca
Sint Franciscus Gasthuis
Clinical Trial Overview of Sint Franciscus Gasthuis
Ottawa Hospital Research Institute
Clinical Trial Overview of Ottawa Hospital Research Institute
The Oregon Clinic
Clinical Trial Overview of The Oregon Clinic
Hospital Universitario Central de Asturias
Clinical Trial Overview of Hospital Universitario Central de Asturias
Christian Medical College
Clinical Trial Overview of Christian Medical College
Queen Mary, University of London
Clinical Trial Overview of Queen Mary, University of London
Mount Sinai School of Medicine
Clinical Trial Overview of Mount Sinai School of Medicine
University of Patras
Clinical Trial Overview of University of Patras
Akershus University Hospital
Clinical Trial Overview of Akershus University Hospital
Cliniques Universitaires Saint-Luc
Clinical Trial Overview of Cliniques Universitaires Saint-Luc
Legacy Health System
Clinical Trial Overview of Legacy Health System
Imperial College London
Clinical Trial Overview of Imperial College London
University of Hull
Clinical Trial Overview of University of Hull
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
List of Tables
Fistula Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Fistula Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Fistula Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Fistula Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012*
Fistula Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Fistula Therapeutics Clinical Trials, North America, Top Countries, 2012*
Fistula Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012*
China Pharmaceutical Guidebook Series (3) 2013 - Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Biological Products